← Eichor
Study identifier: NCT06471413 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of the Effect of the BOAT® Structured Prevention Program on Violence in Middle Schools

Condition: Students · Middle Schools · Prevention  ·  Sponsor: University Hospital, Montpellier

PhaseN/A
Planned participants5400
Who can joinAll sexes, 13 Years to 17 Years
Healthy volunteersYes

About this study

Violence has major consequences for the health and development of children and teenagers, even though it is commonplace, particularly in secondary schools. The team at the Centre Ressources pour les Intervenants auprès d'Auteurs de Violences Sexuelles Languedoc-Roussillon (CRIAVS-LR, CHU Montpellier) has created a BOite A ouTils to prevent sexual and gender-based violence: the BOAT, for professionals working with children and teenagers aged between 5 and 18. Structured around 5 themes and 4 age groups, the BOAT is very easy to use. The 134 intervention sheets have been validated and designed to target a risk factor (to be reduced) or a protective factor (to be developed) so that children do not become perpetrators or victims of violence.

This description comes directly from the study's public registry record.

Talk to the study team

Mathieu LACAMBRE, PH  ·  0467338577  ·  m-lacambre@chu-montpellier.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU de MONTPELLIERMontpellier, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06471413